Search research articles
Contact Us
Filters
Showing results (931-940 of 973) with videos related to
Page
of 98
Sort By:
The Journal of Clinical Investigation
|
October 25, 2022
3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma
Ya'an Kang, Jenying Deng, Jianhua Ling, et al.
Oncotarget
|
March 31, 2018
Dynamic changes during the treatment of pancreatic cancer
Robert A Wolff, Andrea Wang-Gillam, Hector Alvarez, et al.
The Lancet. Oncology
|
February 23, 2017
Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study
Van K Morris, Mohamed E Salem, Halla Nimeiri, et al.
Annals of Surgery
|
April 7, 2023
Effects of a Pragmatic Home-based Exercise Program Concurrent With Neoadjuvant Therapy on Physical Function of Patients With Pancreatic Cancer: The PancFit Randomized Clinical Trial
An T Ngo-Huang, Nathan H Parker, Lianchun Xiao, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
A spatial atlas of chemoradiation therapy in pancreatic cancer identifies cellular and microenvironmental determinants of persister populations
Vincent Bernard, Li-Ting Ku, Tianyu Wang, et al.
Cell Reports
|
January 14, 2023
Defining the age-dependent and tissue-specific circadian transcriptome in male mice
Christopher A Wolff, Miguel A Gutierrez-Monreal, Lingsong Meng, et al.
Oncology
|
October 7, 2020
Impact of Integrating Insulin-Like Growth Factor 1 Levels into Model for End-Stage Liver Disease Score for Survival Prediction in Hepatocellular Carcinoma Patients
Reham Abdel-Wahab, Manal M Hassan, Bhawana George, et al.
Cancer
|
January 26, 2018
Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy
Ahmed M Amer, Mohamed Zaid, Baishali Chaudhury, et al.
Gut
|
April 23, 2025
Long-chain sulfatide enrichment is an actionable metabolic vulnerability in intraductal papillary mucinous neoplasm (IPMN)-associated pancreatic cancers
Yihui Chen, Riccardo Ballarò, Marta Sans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2019
Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNA
Ahmed O Kaseb, Nora S Sánchez, Shiraj Sen, et al.
Page
of 98
Search research articles
Search
Showing results (931-940 of 973) with videos related to
Sort By:
Page
of 98
The Journal of Clinical Investigation
|
October 25, 2022
3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma
Ya'an Kang, Jenying Deng, Jianhua Ling, et al.
Oncotarget
|
March 31, 2018
Dynamic changes during the treatment of pancreatic cancer
Robert A Wolff, Andrea Wang-Gillam, Hector Alvarez, et al.
The Lancet. Oncology
|
February 23, 2017
Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study
Van K Morris, Mohamed E Salem, Halla Nimeiri, et al.
Annals of Surgery
|
April 7, 2023
Effects of a Pragmatic Home-based Exercise Program Concurrent With Neoadjuvant Therapy on Physical Function of Patients With Pancreatic Cancer: The PancFit Randomized Clinical Trial
An T Ngo-Huang, Nathan H Parker, Lianchun Xiao, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
A spatial atlas of chemoradiation therapy in pancreatic cancer identifies cellular and microenvironmental determinants of persister populations
Vincent Bernard, Li-Ting Ku, Tianyu Wang, et al.
Cell Reports
|
January 14, 2023
Defining the age-dependent and tissue-specific circadian transcriptome in male mice
Christopher A Wolff, Miguel A Gutierrez-Monreal, Lingsong Meng, et al.
Oncology
|
October 7, 2020
Impact of Integrating Insulin-Like Growth Factor 1 Levels into Model for End-Stage Liver Disease Score for Survival Prediction in Hepatocellular Carcinoma Patients
Reham Abdel-Wahab, Manal M Hassan, Bhawana George, et al.
Cancer
|
January 26, 2018
Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy
Ahmed M Amer, Mohamed Zaid, Baishali Chaudhury, et al.
Gut
|
April 23, 2025
Long-chain sulfatide enrichment is an actionable metabolic vulnerability in intraductal papillary mucinous neoplasm (IPMN)-associated pancreatic cancers
Yihui Chen, Riccardo Ballarò, Marta Sans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2019
Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNA
Ahmed O Kaseb, Nora S Sánchez, Shiraj Sen, et al.
Page
of 98